Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
The Faculty of Science at Leiden University is offering a new opportunity for professionals to deepen their knowledge of data-driven decision-making, complex systems, and algorithmic thinking.
As part of a national pilot on microcredentials, three English-taught courses will be available this September through the Mathematical Institute (MI):
Complex Networks: Learn how to analyze and influence systems like traffic flows, social media, and energy networks.
Interactive Machine Learning: Explore how algorithms can adapt and support decision-making under uncertainty.
Algorithms in Algebra: Gain insight into the mathematics behind algorithms with applications in cryptography and computational science.
Each course provides practical tools and academic rigor, and participants will receive a microcredential, a digital certificate that can be added to their CV and LinkedIn profile.
Courses are held in person at the Gorlaeus building in Leiden and run during the first semester of the academic year. Registration is open until 15 August 2025.
Learn more: https://www.universiteitleiden.nl/wiskunde-en-natuurwetenschappen/onderwijs/onderwijs-voor-professionals
These courses are especially relevant for professionals in biotech, data science, or engineering fields who want to strengthen their analytical and modeling skills.
For questions or collaboration inquiries, contact Leontine Heisen, Senior Communications Advisor at the Faculty of Science.
As of June, the Leiden Bio Science Park team has been joined by Gerwin Zomer, who steps into the role of Account Manager Physical Living Environment. To get to know him a bit...
Researchers at the Leiden University Medical Center (LUMC) have announced promising early results from a clinical trial using lab-grown insulin-producing islet cells derived from...
VarmX has received IND approval for its Phase 3 trial of VMX‑C001, a recombinant factor X variant designed to neutralize FXa‑inhibiting anticoagulants during emergency surgery. Backed by robust Phase 1 data and boosted by a €15 million EIC investment, this step positions VMX‑C001 to meet a gap in urgent haemostasis care.